Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Clean Earth Acquisitions Corp. Cl A (CLIN)

Clean Earth Acquisitions Corp. Cl A (CLIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 83,520
  • Shares Outstanding, K 16,704
  • Annual Sales, $ 0 K
  • Annual Income, $ 60 K
  • 60-Month Beta -0.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLIN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.54 +10.13%
on 12/11/23
10.66 -53.10%
on 11/27/23
-5.89 (-54.09%)
since 11/21/23
3-Month
4.54 +10.13%
on 12/11/23
10.89 -54.09%
on 11/21/23
-5.56 (-52.65%)
since 09/21/23
52-Week
4.54 +10.13%
on 12/11/23
11.36 -55.99%
on 04/17/23
-5.05 (-50.25%)
since 12/22/22

Most Recent Stories

More News
Alternus Energy Group plc Announces Altnua, a Dedicated Clean Energy Development Business to Drive Organic Growth into the Future

Alternus Energy Group plc ("Alternus") (OSE: ALT) today announced the establishment of its development business, Altnua, which aims to become one of the leading specialist renewable asset developers in...

ALT : 6.91 (+0.29%)
CLIN : 5.00 (-12.28%)
Alternus Energy Group Plc Announces Business Combination Agreement with Clean Earth Acquisitions Corp.

Alternus Energy Group Plc (" Alternus " or the " Company ") (OSE: ALT) and Clean Earth Acquisitions Corp. (NASDAQ: CLIN) (“ Clean Earth ”), a climate technology and energy transition-focused special...

ALT : 6.91 (+0.29%)
CLIN : 5.00 (-12.28%)
Humanigen Launches Managed Access Program for Lenzilumab

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced today that lenzilumab is now...

CLIN.LN : 925.000 (unch)
HGEN : 0.0002 (-84.62%)
CLIN : 5.00 (-12.28%)
Clinigen Expands Partnership With Accord Healthcare in Clinical Services Into France

Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that its Clinical Services (CS) business has expanded its exclusive ’on-demand’ supply service...

CLIN.LN : 925.000 (unch)
CLIN : 5.00 (-12.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar